Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Schulte

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Current Opinion in Lipidology|July 4, 2003
Inflammation in atherosclerosis, not yet time for a paradigm shift?Paul Cullen, Stefan Lorkowski, Helmut Schulte, et al.
Current Medical Research and Opinion|November 10, 2010
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory careKurt Bestehorn, Wenefrieda Smolka, David Pittrow, et al.
European Heart Journal|April 26, 2003
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohortsHans-Werner Hense, Helmut Schulte, Hannelore Löwel, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 27, 2006
Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation)Gerd Assmann, Heike Benecke, Albrecht Neiss, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM studyAnette E Buyken, Arnold von Eckardstein, Helmut Schulte, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 10, 2006
Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) studyGerd Assmann, Paul Cullen, John Erbey, et al.
Clinical Chemistry and Laboratory Medicine|April 22, 2005
Interferences in coagulation tests--evaluation of the 570-nm method on the Dade Behring BCS analyserRalf Junker, Margit Käse, Helmut Schulte, et al.
The American Journal of Cardiology|February 13, 2007
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populationsGerd Assmann, Rudy Guerra, Garrett Fox, et al.
Clinical Cardiology|October 16, 2008
Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failureJörg Stypmann, Aurelien Schubert, Henryk Welp, et al.
Clinical Endocrinology|November 4, 2004
Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart diseaseFrank Fischer, Helmut Schulte, Subburaman Mohan, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Lipidology|July 4, 2003
Inflammation in atherosclerosis, not yet time for a paradigm shift?Paul Cullen, Stefan Lorkowski, Helmut Schulte, et al.
Current Medical Research and Opinion|November 10, 2010
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory careKurt Bestehorn, Wenefrieda Smolka, David Pittrow, et al.
European Heart Journal|April 26, 2003
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohortsHans-Werner Hense, Helmut Schulte, Hannelore Löwel, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 27, 2006
Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation)Gerd Assmann, Heike Benecke, Albrecht Neiss, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM studyAnette E Buyken, Arnold von Eckardstein, Helmut Schulte, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 10, 2006
Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) studyGerd Assmann, Paul Cullen, John Erbey, et al.
Clinical Chemistry and Laboratory Medicine|April 22, 2005
Interferences in coagulation tests--evaluation of the 570-nm method on the Dade Behring BCS analyserRalf Junker, Margit Käse, Helmut Schulte, et al.
The American Journal of Cardiology|February 13, 2007
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populationsGerd Assmann, Rudy Guerra, Garrett Fox, et al.
Clinical Cardiology|October 16, 2008
Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failureJörg Stypmann, Aurelien Schubert, Henryk Welp, et al.
Clinical Endocrinology|November 4, 2004
Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart diseaseFrank Fischer, Helmut Schulte, Subburaman Mohan, et al.
Pageof 3